Insights On Trial Design

31. Global Prevalence And Clinical Trials Landscape Of AML 4/8/2024

    Explore the advancements in Acute Myeloid Leukaemia treatments, specifically innovative drugs, ongoing clinical trials, and their potential impact on patient outcomes.

32. Ocular Endpoint Protection In A Capital-Constrained Market 9/3/2025

    Ocular Endpoint Protection reframes data capture as a non-negotiable driver of efficiency, and sponsors who embed point-of-need (PON) into their protocols protect both their investment and results.

33. Building Successful Studies: A Proven Framework 10/1/2024

    To gain a deeper understanding of successful study design, this article explores study personas, core design, a seven-step process for post go-live (PGL) changes, and more.

34. Reducing The Travel Burden For Patients - The Benefits Of Mobile Vision Clinics 3/11/2025

    Travel to trial sites can be a major hurdle for patients considering participation, but mobile vision clinics are providing a solution to improve accessibility, capacity, and patient enrollment.

35. Operational Excellence In An International Clinical Research Site Network 5/13/2025

    This case study highlights operational excellence within a global clinical trial for osteoporosis, underscoring the critical role of site networks in achieving research success.

36. Developing And Validating Clinical Receptor Occupancy Pharmacodynamic Biomarker Assays 9/25/2025

    Receptor occupancy (RO) assays assess drug-target engagement and support PK/PD modeling. Accurate RO requires customized assays using stabilized blood to monitor CD6 modulation in autoimmune therapy.

37. The Future Of Patient Participation In Clinical Research 2/18/2025

    To address challenges such as limited patient awareness, mistrust, and logistical barriers, the industry must embrace technology-driven solutions and community-centered outreach.

38. What Is Citeline Connect? 9/24/2024

    Explore a centralized patient recruitment platform that enables sponsors to meet their enrollment goals using a diverse selection of channels and recruitment partners.

39. Patient Diversity: Identifying Challenges, Opportunities, And Best Practices 4/10/2024

    By listening to the voice of patient diversity and implementing FDA guidance measures, learn how stakeholders can improve trust, engagement, data reliability, patient outcomes, and promote public health.

40. Optimizing Prader-Willi Syndrome Clinical Trials 10/21/2024

    Learn how Signant is helping to mitigate placebo responses and ensuring high-quality data to improve Prader-Willi syndrome (PWS) clinical trial success.